CHRONIC TREATMENT WITH BRL-35135 POTENTIATES THE ACTION OF INSULIN ONLIPID-METABOLISM

Citation
Ka. Virtanen et al., CHRONIC TREATMENT WITH BRL-35135 POTENTIATES THE ACTION OF INSULIN ONLIPID-METABOLISM, European journal of pharmacology, 332(2), 1997, pp. 215-218
Citations number
14
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
332
Issue
2
Year of publication
1997
Pages
215 - 218
Database
ISI
SICI code
0014-2999(1997)332:2<215:CTWBPT>2.0.ZU;2-H
Abstract
The effects of a beta(3)-adrenoceptor agonist on insulin-induced chang es in lipid metabolism were studied in obese male Zucker (fa/fa) rats during euglycaemic clamp. Rats were treated with BRL 35135 -chlorophen yl)-ethyl-amino]-propyl]-phenoxyacetate hydrobromide) (0.5 mg/kg per d ay in drinking water) for three weeks before an euglycaemic hyperinsul inaemic clamp was performed. Insulin infusion lowered serum non-esteri fied fatty acids and plasma glycerol more efficiently in BRL 35135-tre ated than in control rats although plasma insulin remained significant ly lower in the BRL 35135-treated than in the control rats during the clamp. In conclusion, chronic treatment with BRL 35135 potentiates the effect of insulin on lipid metabolism. (C) 1997 Elsevier Science B.V.